Related references
Note: Only part of the references are listed.Quality control and product differentiation of LMWHs marketed in China using 1H NMR spectroscopy and chemometric tools
Haipeng Jiang et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2022)
Chemobiocatalytic Synthesis of a Low-Molecular-Weight Heparin
Yanlei Yu et al.
ACS CHEMICAL BIOLOGY (2022)
Multiplex genome editing of mammalian cells for producing recombinant heparin
Bryan E. Thacker et al.
METABOLIC ENGINEERING (2022)
Influence of saccharide modifications on heparin lyase III substrate specificities
Jiandong Wu et al.
GLYCOBIOLOGY (2022)
Fluorometric coupled enzyme assay for N-sulfotransferase activity of N-deacetylase/N-sulfotransferase (NDST)
Joshua Atienza et al.
GLYCOBIOLOGY (2021)
Chemoenzymatic synthesis of ultralow and low-molecular weight heparins
Ting Wang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2020)
ZNF263 is a transcriptional regulator of heparin and heparan sulfate biosynthesis
Ryan J. Weiss et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Anticoagulant and signaling functions of antithrombin
Alireza R. Rezaie et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2020)
A Revised Structure for the Glycolipid Terminus of Escherichia coli K5 Heparosan Capsular Polysaccharide
Lufeng Yan et al.
BIOMOLECULES (2020)
Substrate binding mode and catalytic mechanism of human heparan sulfate D-glucuronyl C5 epimerase
Claire Debarnot et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2019)
Imminent risk of a global shortage of heparin caused by the African Swine Fever afflicting the Chinese pig herd
Eduardo Vilanova et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2019)
Specificity and action pattern of heparanase Bp, a β-glucuronidase from Burkholderia pseudomallei
Yanlei Yu et al.
GLYCOBIOLOGY (2019)
Enzymatic Generation of Highly Anticoagulant Bovine Intestinal Heparin
Li Fu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2017)
Structural Analysis of Heparin-Derived 3-O-Sulfated Tetrasaccharides: Antithrombin Binding Site Variants
Yin Chen et al.
JOURNAL OF PHARMACEUTICAL SCIENCES (2017)
Modernization of Enoxaparin Molecular Weight Determination Using Homogeneous Standards
Katelyn M. Arnold et al.
PHARMACEUTICALS (2017)
Bioengineered heparins and heparan sulfates
Li Fu et al.
ADVANCED DRUG DELIVERY REVIEWS (2016)
Screening enoxaparin tetrasaccharide SEC fractions for 3-O-sulfo-N-sulfoglucosamine residues using [1H,15N] HSQC NMR
Consuelo N. Beecher et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2016)
Pharmacology of Heparin and Related Drugs
Barbara Mulloy et al.
PHARMACOLOGICAL REVIEWS (2016)
Differentiation of Generic Enoxaparins Marketed in the United States by Employing NMR and Multivariate Analysis
Marco Guerrini et al.
ANALYTICAL CHEMISTRY (2015)
High Cell Density Cultivation of Recombinant Escherichia coli Strains Expressing 2-O-Sulfotransferase and C5-Epimerase for the Production of Bioengineered Heparin
Jianhua Zhang et al.
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY (2015)
Functional and structural characterization of a heparanase
Lisa Bohlmann et al.
NATURE CHEMICAL BIOLOGY (2015)
High cell density cultivation of a recombinant Escherichia coli strain expressing a 6-O-sulfotransferase for the production of bioengineered heparin
J. Zhang et al.
JOURNAL OF APPLIED MICROBIOLOGY (2015)
Synthesis of the Heparin-Based Anticoagulant Drug Fondaparinux
Cheng-Hsiu Chang et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Microbial heparin/heparan sulphate lyases: potential and applications
C. K. M. Tripathi et al.
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY (2012)
Response surface optimization of the heparosan N-deacetylation in producing bioengineered heparin
Zhenyu Wang et al.
JOURNAL OF BIOTECHNOLOGY (2011)
Solution structures of chemoenzymatically synthesized heparin and its precursors
Zhenqing Zhang et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Heparin and low-molecular-weight heparin
Elaine Gray et al.
THROMBOSIS AND HAEMOSTASIS (2008)
Product individuality of commercially available low-molecular-weight heparins and their generic versions: Therapeutic implications
Jyothi Maddineni et al.
CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS (2006)
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer
AYY Lee et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
2003 Claude S. Hudson Award address in carbohydrate chemistry. Heparin: Structure and activity
RJ Linhardt
JOURNAL OF MEDICINAL CHEMISTRY (2003)
First isolation of human UDP-D-xylose:: Proteoglycan core protein β-D-xylosyltransferase secreted from cultured JAR choriocarcinoma cells
J Kuhn et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)